Tumor Microenvironment: No Effector T Cells without Dendritic Cells
- PMID: 28486102
- DOI: 10.1016/j.ccell.2017.04.007
Tumor Microenvironment: No Effector T Cells without Dendritic Cells
Abstract
Successful antitumor immunity is thought to require T cell entry into tumors, though mechanisms regulating this process remain unclear. In this issue of Cancer Cell, Spranger et al. indicate that chemokines produced by intratumoral Batf3 dendritic cells are critical for effector T cell recruitment. The findings have implications for immunotherapy.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.Cancer Cell. 2017 May 8;31(5):711-723.e4. doi: 10.1016/j.ccell.2017.04.003. Cancer Cell. 2017. PMID: 28486109 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
